Overdose Review Team Act
Bill: S.4091 | Sponsor: Sen. Whitehouse, Sheldon (D-RI)
Policy area: Health

Summary:
Overdose Review Team Act
This bill provides funding to the Department of Health and Human Services for grants that support drug overdose fatality review teams in states, Indian tribes, territories, and localities. These multidisciplinary teams track fatal and nonfatal drug overdoses that occur in the jurisdiction to identify relevant trends and patterns and recommend policies and practices for preventing and reducing drug overdoses.

To amend part A of title XI of the Social Security Act to provide 
   grants to States, units of local government, and Indian Tribes to 
  establish, expand, or maintain Drug Overdose Fatality Review Teams.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Overdose Review Team Act''.

SEC. 2. FUNDING TO ESTABLISH DRUG OVERDOSE FATALITY REVIEW TEAMS.

    Part A of title XI of the Social Security Act (42 U.S.C. 1301 et 
seq.) is amended by adding at the end the following:

``SEC. 1150D. GRANTS TO ESTABLISH DRUG OVERDOSE FATALITY REVIEW TEAMS.

    ``(a) Grants.--The Secretary shall, using amounts appropriated 
under this section, award grants to States, units of local government, 
and Indian Tribes to establish, expand, or maintain a Drug Overdose 
Fatality Review Team, which shall--
            ``(1) promote cooperation and coordination among agencies 
        involved in the investigation of fatal and non-fatal drug 
        overdoses;
            ``(2) develop an understanding of the causes and incidences 
        of drug overdoses in the jurisdiction where the team operates;
            ``(3) track the total number of drug overdose deaths and 
        identify trends and patterns in fatal and non-fatal drug 
        overdoses in the jurisdiction where the team operates;
            ``(4) plan for and recommend changes within the agencies to 
        prevent drug overdose fatalities;
            ``(5) recommend best practices for preventing drug 
        overdoses and drug overdose deaths; and
            ``(6) advise policymakers in the team's jurisdiction about 
        potential changes to law, policy, funding, or practices to 
        prevent drug overdoses.
    ``(b) Grant Recipients.--The Secretary shall not award grant funds 
under this section to a recipient unless the recipient provides to the 
Secretary a list of individuals on the drug overdose fatality review 
team, which shall include--
            ``(1) not less than 1 representative each from--
                    ``(A) the State, local, or Tribal department of 
                health, or similar department;
                    ``(B) the State, local, or Tribal governmental 
                entity responsible for alcohol, drug, or other 
                substance addiction treatment and services;
                    ``(C) the State, local, or Tribal department of 
                social services, or similar department;
                    ``(D) the State, local or Tribal attorney's office;
                    ``(E) law enforcement agencies of the jurisdiction, 
                which may include representatives of law enforcement 
                agencies operating in a high intensity drug trafficking 
                area designated pursuant to section 707(b) of the 
                Office of National Drug Control Policy Reauthorization 
                Act of 1998 (21 U.S.C. 1706(b));
                    ``(F) the State, local, or Tribal department of 
                corrections, or similar department; and
                    ``(G) the State, local or Tribal medical examiner 
                or coroner;
            ``(2) a health care provider who specializes in the 
        diagnosis and treatment of substance use and misuse and 
        substance use disorders;
            ``(3) a health care provider who specializes in treating 
        co-occurring mental health and substance use disorders;
            ``(4) a representative from emergency medical services;
            ``(5) a patient advocate who has lived experience with 
        substance use and misuse or who has a family member with a 
        history of substance use and misuse;
            ``(6) an emergency department physician;
            ``(7) a toxicologist; and
            ``(8) a community-based substance use prevention coalition 
        leader or other community-based substance use prevention 
        professional.
    ``(c) Appropriation.--In addition to amounts otherwise available, 
there is appropriated to the Secretary for fiscal year 2023, out of any 
money in the Treasury not otherwise appropriated, $50,000,000, to 
remain available until 2027, to carry out this section.
    ``(d) Definitions.--In this section:
            ``(1) Indian tribe.--The term `Indian Tribe' has the 
        meaning given that term in section 4(e) of the Indian Self-
        Determination and Education Assistance Act (25 U.S.C. 5304(e)).
            ``(2) State.--The term `State' has the meaning given that 
        term in section 1101(a)(1) for purposes of this title and 
        includes the Commonwealth of the Northern Mariana Islands, and 
        American Samoa.''.
                                 <all>